Selectra SICAV Investments – J. LAMARCK BIOTECH


Inception: 26/01/2011

Inv. Manager: SELECTRA Management Company S.A.

Inv. Advisor: J.LAMARCK S.p.A.

Strategy: The focus is on mature top tier pharmaceutical biotech companies and companies with interesting pipeline of products in development in a single or numerous markets, like NASDAQ or NYSE. The followed investment policy will enable the Sub-Fund to increase overall return relative to the Nasdaq Biotech Index by active stock selection of companies, offering the most promising technology platform.

Geographical Area: Worldwide

Asset Class: Equity Fund